Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.burns.2019.11.026 | DOI Listing |
Hepatobiliary Surg Nutr
December 2024
Upper Gastrointestinal Surgery Unit, Division of Surgery, Anaesthesia and Procedural Medicine, Austin Health, Heidelberg, Victoria, Australia.
Hepatobiliary Surg Nutr
December 2024
Department of Surgery, University of Ottawa, The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
COVID-19-related critical and acute illness are associated with an increased risk of venous thromboembolism (VTE). These evidence-based recommendations of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other healthcare professionals in decisions about the use of anticoagulation for thromboprophylaxis in patients with COVID-19-related critical illness, acute illness, and those being discharged from the hospital, who do not have suspected or confirmed VTE. ASH formed a multidisciplinary panel, including three patient representatives, and applied a conflicts of interest management policy to minimize potential bias.
View Article and Find Full Text PDFBr J Haematol
August 2024
Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Venous thromboembolism (VTE) remains a significant cause of morbidity and mortality among multiple myeloma patients. Chang and colleagues' findings indicate that factor Xa inhibitors are as effective as warfarin in preventing VTE without raising the risk of gastrointestinal or intracranial bleeding complications. Commentary on: Chang et al.
View Article and Find Full Text PDFJ R Coll Physicians Edinb
June 2024
British Medical Association, London, UK.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!